Acceleron Pharma to Participate in Two Healthcare Investor Conferences in February
01 Febrero 2016 - 6:00AM
Business Wire
Acceleron Pharma Inc. (NASDAQ:XLRN), a clinical stage
biopharmaceutical company focused on the discovery, development and
commercialization of novel therapeutic candidates that regulate
cellular growth and repair, today announced that senior management
will participate in two upcoming healthcare investor
conferences.
Conference Details:
Event:
LEERINK Partners 5th Annual Global
Healthcare Conference
Date / Time:
Wednesday, February 10, 2016 at 1:50 PM
EST
Location:
Waldorf Astoria, New York, NY
Event:
SunTrust Robinson Humphrey 2016 Orphan
Drug Day
Date / Time:
Tuesday, February 23, 2016
Location:
JW Marriot Essex House, New York, NY
A live audio webcast of the fireside chat at the LEERINK
conference will be available on the “Events and Presentations” page
in the Investors & Media section on the Company’s website
(www.acceleronpharma.com). A replay of the webcast will also be
available from Acceleron’s website.
About Acceleron
Acceleron is a clinical stage biopharmaceutical company focused
on the discovery, development and commercialization of novel
therapeutic candidates that regulate cellular growth and repair.
The company is a leader in understanding the biology of the
Transforming Growth Factor-Beta protein superfamily, a large and
diverse group of molecules that are key regulators in the growth
and repair of tissues throughout the human body, and in targeting
these pathways to develop important new medicines. Acceleron has
built a highly productive R&D platform that has generated
innovative clinical and preclinical therapeutic candidates with
novel mechanisms of action. These therapeutic candidates have the
potential to significantly improve clinical outcomes for patients
with cancer and rare diseases.
For more information, please visit www.acceleronpharma.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160201005377/en/
Acceleron Pharma Inc.Todd James, 617-649-9393Senior Director,
Investor Relations and Corporate CommunicationsorMedia:BMC
Communications LLCBrad Miles, 646-513-3125
Acceleron Pharma (NASDAQ:XLRN)
Gráfica de Acción Histórica
De Jun 2024 a Jul 2024
Acceleron Pharma (NASDAQ:XLRN)
Gráfica de Acción Histórica
De Jul 2023 a Jul 2024
